- 1992 – BBA (Hons) in Management, St. Francis Xavier University, Nova Scotia, Canada
- 1996 – MBA in Finance and Strategy, INSEAD, Fontainebleau, France
David joined Sona Nanotech as a consultant in the spring of 2020 to provide strategic advisory with respect to its commercialization and capital markets strategies as the company plotted a path toward developing and taking its COVID-19 test to market. In July of 2020 he was named CEO with the mandate to secure third party evaluations of the test, manufacturing capacity via contract manufacturing organizations, regulatory approvals and, ultimately, sales.
He has 25 years’ experience in finance, international business, innovation, M&A and capital markets. He has previously led corporate strategy and M&A function at a dual-listed public company, been an innovation consultant and provided financial advisory services.
Sailing, kite surfing, hockey, running, skiing and spending time with family.
In his own words
“Strategic thinking entails assessing tactical steps not on their own merits but on how they serve to get you to your long-term goals.”